Carigent Therapeutics

About:

Carigent Therapeutics is a biotechnology company that develops therapeutic agents.

Top Investors: Saint Simeon Marketing and Investments

Description:

Carigent Therapeutics is a biotechnology company that develops therapeutic agents. It offers a drug delivery platform for releasing therapeutic agents, targeting therapy to physiological sites, tethering surface ligands, and combining multiple agents. The company’s products are used in various applications such as genetic, systemic, and oncology diseases. Carigent Therapeutics was incorporated in 2006 and is based in New Haven, Connecticut, United States.

Total Funding Amount:

$2M

Headquarters Location:

New Haven, Connecticut, United States

Founded Date:

2006-01-01

Founders:

Bill Wiesler

Number of Employees:

1-10

Last Funding Date:

2007-12-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai